Position Yourself as the Go-To Partner in AI/ML-Enabled Small Molecule Discovery
As the small molecule discovery space accelerates, aided by AI/ML powered approaches, developers are actively seeking innovative, reliable partners to support their discovery programs from target enablement, to hit identification and lead optimization. With more biopharma investing into AI/ML technologies, competition is growing, making it essential to stand out as the preferred partner of choice.
The AI Convergence: Small Molecule Discovery Summit offers you the unique opportunity to promote your capabilities, build brand recognition, and align yourself with the next wave of small molecule innovators.
Whether you are ready to showcase your services or looking to quietly scout the market and establish presence, being present ensures your name is noticed by key decision-makers across the biopharma landscape.
Identify how your team can best engage with the small molecule discovery community by joining the conversation, building strategic relationships, or positioning your services as a leader in the AI/ML-enabled small molecule discovery space.
Make Partnering Your Priority:
Meet New Clients & Collaborators
Expand your client base by networking face-to-face with dedicated attendees actively seeking solutions and partners to address their AI small molecule discovery challenges.
Centre Yourself in Biopharma Deal-Making
Build your brand awareness amongst C-suite decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Spotlight Your Expertise
Present your work to a targeted audience, co-lead a workshop or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of latest industry trends and growth opportunities by hearing directly from key thought leaders. Access competitor insights and strategies to shape your organization’s future and sharpen its competitive edge.
Key Services & Solutions
Our attendees from pharma, techbio, biotech and academia need service and solution providers with capabilities in, but not limited to, the below areas:
What Our Experts Have to Say:
Data is an essential component for any AI effort. This program brings together several efforts around the most critical components of AI and ML workflows
Pat Walters, Chief Scientist, OpenADMET,
2026 Speaker
It’s always great to learn more about how different people are solving challenges in drug discovery with state-of-the-art AI technologies, given how fast it is evolving
Hok Hei Tam, Co-Founder & Chief Technology Officer, Montai Therapeutics & Senior Principal, Flagship Pioneering, 2026 Speaker
Audience Composition:
Company Type
Attendee Seniority
*Statistics Taken from the 10th Computational Drug Design for Biologics Summit
Attending Companies:
Bespoke Partnership Opportunities Available Include:
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as badges and exclusive dinners to help elevate your brand.
Get in Touch:
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Tazeen Kapadia
Partnerships Director
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Hear the Latest Breakthroughs
Participate in conversations with top biopharma experts to ensure your services are aligned with the needs of your clients.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.